Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RLMDRLMD
Showing 8 of 27 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Relmada Therapeutics Inc

GEODE CAPITAL MANAGEMENT, LLC holds 2.5M shares of RLMD (Relmada Therapeutics Inc), worth $17.3M as of 2026-Q2. The position was increased (+193.7% shares). RLMD represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$17.3M

Current Shares

2.5M

Total Value Change

+$16.3M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+193.7%
$17.3M0.0%$6.92
46
2026-Q1
Decreased
848,683
-0.7%
$5.9M0.0%$4.67
0
2025-Q4
Increased
854,932
+188.6%
$4.1M0.0%$4.53
43
2025-Q3
Decreased
296,215
-2.0%
$595,5330.0%$1.88
0
2025-Q2
Increased
302,354
+0.2%
$181,5410.0%$0.61
15
2025-Q1
Decreased
301,883
-0.3%
$81,5290.0%$0.30
0
2024-Q4
Decreased
302,838
-0.6%
$157,5160.0%$0.46
0
2024-Q3
Increased
304,502
+16.9%
$986,7910.0%$3.37
29

Other major holders of RLMD: RTW INVESTMENTS, LP, Jupiter Topco LLC, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used